A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track ...
TipRanks on MSN
PepGen price target raised to $3 from $1 at BofA
BofA raised the firm’s price target on PepGen (PEPG) to $3 from $1 and keeps an Underperform rating on the shares. The firm updated its model to ...
UCL Swift’s strategy for growth in the U.S. takes another step forward as it launches its line of domestically manufactured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback